Recommendations Russian Society of Dermatovenerologists and Cosmetologists for systemic treatment of psoriasis during the pandemic COVID-19
- Authors: Kubanov A.A.1, Bakulev A.L.1, Kokhan M.M.1, Olisova O.Y.1, Samtsov A.V.1, Sokolovskiy E.V.1, Khairutdinov V.R.1, Khobeish M.M.1
-
Affiliations:
- All-Russian Public Organization “Russian Society of Dermatovenerologists and Cosmetologists”
- Issue: Vol 96, No 2 (2020)
- Pages: 9-13
- Section: EDITORIAL
- URL: https://journal-vniispk.ru/0042-4609/article/view/117489
- DOI: https://doi.org/10.25208/vdv1129
- ID: 117489
Cite item
Full Text
Abstract
Below you will find the analysis of the first published data and international clinical recommendations for the systemic treatment of patients with moderate and severe psoriasis in the context of the COVID-19 pandemic in different countries (France, Italy, USA, Spain, and Germany).
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Alexey A. Kubanov
All-Russian Public Organization “Russian Society of Dermatovenerologists and Cosmetologists”
Author for correspondence.
Email: alex@cnikvi.ru
Dr. Sci. (Med.), Prof., Corresponding Member of the Russian Academy of Sciences, Director
Russian Federation, MoscowAndrey L. Bakulev
All-Russian Public Organization “Russian Society of Dermatovenerologists and Cosmetologists”
Email: info@sarderma.ru
ORCID iD: 0000-0002-1450-4942
Dr. Sci. (Med.), Prof., Head of the Department of Dermatology and Cosmetology
Russian Federation, MoscowMuza M. Kokhan
All-Russian Public Organization “Russian Society of Dermatovenerologists and Cosmetologists”
Email: alex@cnikvi.ru
Dr. Sci. (Med.), Prof., Head of the Scientific Clinical Department of Dermatology
Russian Federation, MoscowOlga Yu. Olisova
All-Russian Public Organization “Russian Society of Dermatovenerologists and Cosmetologists”
Email: alex@cnikvi.ru
Dr. Sci. (Med.), Prof., Head of the V.A. Rakhmanov Department of Skin and Venereal Diseases
Russian Federation, MoscowALexey V. Samtsov
All-Russian Public Organization “Russian Society of Dermatovenerologists and Cosmetologists”
Email: alex@cnikvi.ru
Dr. Sci. (Med.), Prof., Head of the Department of Skin and Venereal Diseases
Russian Federation, MoscowEvgeny V. Sokolovskiy
All-Russian Public Organization “Russian Society of Dermatovenerologists and Cosmetologists”
Email: alex@cnikvi.ru
Dr. Sci. (Med.), Prof., Head of the Department of Dermatology and Venereology with a Hospital
Russian Federation, MoscowVladislav R. Khairutdinov
All-Russian Public Organization “Russian Society of Dermatovenerologists and Cosmetologists”
Email: alex@cnikvi.ru
Dr. Sci. (Med.)., Assoc. Prof., Assoc. Prof. of the Department of Skin and Sexually Transmitted Diseases
Russian Federation, MoscowMarianna M. Khobeish
All-Russian Public Organization “Russian Society of Dermatovenerologists and Cosmetologists”
Email: alex@cnikvi.ru
Cand. Sci. (Med.), Assoc. Prof. Department of Dermatology and Venereology with a Hospital
Russian Federation, MoscowReferences
- European Commission. Novel coronavirus 2019-nCoV. URL: https://ec.europa.eu/health/coronavirus_en.
- FDA. Novel coronavirus (2019-nCoV) URL: https://www.fda.gov/emergency-preparedness-and response/mcm-issues/novel-coronavirus-2019-ncov
- Кубанова А. А., Кубанов А. А., Знаменская Л. Ф., Чикин В. В., Бакулев А. Л., Хобейш М. М. и др. Псориаз. В кн.: Федеральные клинические рекомендации. Дерматовенерология, 2015: Болезни кожи. Инфекции, передаваемые половым путем. 5-е изд., перераб. и доп. М.: Деловой экспресс, 2016: 415—470. [Kubanova A.A., Kubanov A.A., Znamenskaya L.F., Chikin V.V., Bakulev A.L., Khobeish M.M., etc. Psoriasis. In: Federal clinical guidelines. Dermatovenereology, 2015: Skin diseases. Sexually transmitted infections. 5th ed., reprint. and add. M.: Business Express, 2016: 415—470 (Russia).]
- Shah P., Zampella J. G. Use of Systemic Immunomodulatory Therapies During the Coronavirus Disease 2019 (COVID-19) Pandemic. 2020 Apr 9. Journal of the American Academy of Dermatology. doi: 10.1016/j.jaad.2020.03.056
- Huang C., Wang Y., Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395 (10223): 497—506.
- Ma W-T., Yao X-T., Peng Q., Chen D-K. The protective and pathogenic roles of IL-17 in viral infections: friend or foe? Open Biology. 2019; 9 (7): 190109.
- Li C., Yang P., Sun Y. et al. IL-17 response mediates acute lung injury induced by the 2009 pandemic influenza A (H1N1) virus. Cell Res. 2012; 22 (3): 528—538.
- Price KN et al. COVID-19 and Immunomodulator/Immunosuppressant Use in Dermatology. J Am Acad Dermatol. 2020 Mar 26. pii: S0190-9622(20)30466-7. doi: 10.1016/j.jaad.2020.03.046.
- https://evenements-sfd.fr/coronavirus-covid-19/
- https://www.sidemast.org/blog/coronavirus
- Hruza G. J., Grant-Kels J. M., Van Beek M/J/ at al/ Guidance on the use of biologic agents during COVID-19 outbreak. AAD. 2020.
- https://aedv.es/?s=covid
- https://aedv.es/coronavirus-los-pacientes-dermatologicos-no-deben-suspender-sus-tratamiento/
- Augustin M., von Kiedrowsky R., Korber A. et al. Recommendations for systemic therapy in persons with psoriasis during the pandemic phase of SARS-COV-2 (corona virus). PsoNet, 2020.
- Wang T., Du Z., Zhu F. et al. Comorbidities and multi-organ injuries in the treatment of COVID-19. Lancet. 2020.
- Yang J., Zheng Y., Gou X. et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 2020.
- Fang L., Karakiulakis G. Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020.
Supplementary files
